Federal appeals court upholds mandatory anthrax vaccinations for military News
Federal appeals court upholds mandatory anthrax vaccinations for military

[JURIST] The US Court of Appeals for the District of Columbia Circuit [official website] on Tuesday upheld [opinion, PDF] a mandatory anthrax vaccination program [official website] for some members of the military. The appeals court affirmed a February 2008 district court ruling that dismissed [opinion, PDF; JURIST report] a lawsuit brought by members of the US Department of Defense (DOD) [official website] seeking to make an anthrax vaccine optional rather than mandatory. The lawsuit challenged the determination of the Food and Drug Administration (FDA) [official website] that there was sufficient evidence of the vaccine's effectiveness since it had been based on a single study conducted in the 1950s with an earlier generation of the anthrax vaccine. The appeals court deferred to the FDA's determination, finding that it was:

a scientific judgment within its "area of expertise," the kind of judgment to which this court gives a "high level of deference." Moreover, as the plaintiffs themselves concede, there is no scientific evidence in the administrative record to contradict that judgment. In the absence of such evidence, we must defer to the FDA's judgment that [the anthrax vaccine] is effective.

The appeals court also ruled that the plaintiffs in the suit lacked standing to claim that they have suffered damages due to an allegedly unapproved DOD schedule of inoculations caused by a shortage in the vaccine from 2000 to 2002.

In 2005, the same appeals court ruled in favor of the government, which had asked the court to reinstate [JURIST report] the program. The ruling came after a federal district court ruled [JURIST report] that the DOD could administer anthrax vaccinations only on a voluntary basis. In October 2004, the district court had ordered the DOD to suspend its mandatory vaccination program [JURIST report] because the vaccine had not received proper approval by the FDA. The anthrax was labeled for use by individuals who were at high risk for exposure to the disease, but the Bush administration argued that that definition was broad enough to include military personnel.